Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
A first-in-human trial has shown that CAR-T cells engineered to have a stem cell–like memory phenotype can induce complete remissions in blood cancer patients without the usual chemotherapy ...
Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...
Researchers have developed a sensitive CAR-T therapy that targets 'faint' proteins in solid tumors, potentially transforming cancer treatment.
Examine how large-scale screening of AI-designed binders informs CAR T-cell engineering and functional validation.
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant ...
Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring. USC biomedical engineers have made ...
CAR T cell therapy has transformed blood cancer treatment, but success in solid tumors remains limited by major challenges such as on-target/off-tumor toxicity, poor tumor infiltration, and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results